A stochastic model for circulatory transport in pharmocokinetics

Mathematical Biosciences

Volumn 132, Issue 2, 1996, Pages 141-167

  Lánský, Petr ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TRANSPORT; PROBABILITY; STOCHASTIC MODEL; TIME;

EID: 0342995774     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/0025-5564(95)00050-X     Document Type: Article

References (33)

1. M. Gibaldi and D. Perrier, Pharmacokinetics, Marcel Dekker, New York, 1982.
2. J. M. van Rossum, J. G. M. de Bie, G. van Lingen, and H. W. A. Teeuwen, Pharmacokinetics from a dynamical system point of view, J. Pharmacokin. Biopharmacol. 17:365-397 (1989).
3. J. A. Jacquez, Compartmental Analysis in Biology and Medicine, 2nd ed., Univ. Michigan Press, Ann Arbor, 1985.
4. J. A. Jacquez and C. P. Simon, Qualitative theory of compartmental systems, SIAM Rev. 35:43-79 (1993).
5. D. H. Anderson, J. G. McWilliams, and T. Roller, The unilateral circulation compartmental model, Math. Biosci. 89:183-208 (1988).
6. C. Waterhouse and J. Keilson, Transfer times across the human body, Bull. Math. Biophys. 34:33-44 (1972).
7. M. Weiss, Moments of physiological transit times distributions and the time course of drug disposition in the body, J. Math. Biol. 15:305-318 (1982).
8. M. Weiss, A note on the role of generalized inverse Gaussian distribution of circulatory transit times in pharmacokinetics, J. Math. Biol. 20:95-102 (1984).
9. J. Keilson, A. Kester, and C. Waterhouse, A circulatory model for human metabolism, J. Theor. Biol. 74:535-547 (1978).
10. C. W. Sheppard, Stochastic models for tracer experiments in the circulation. III. The lumped catenary system, J. Theor. Biol. 33:491-515 (1971).
11. D. Verotta and L. B. Sheiner, with an appendix by S. L. Beal, Mean time parameters for generalized physiological flow models (semihomogeneous linear systems), J. Pharmacokin. Biopharmacol. 19:319-331 (1991).
12. M. Weiss, Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves, J. Pharmacokin. Biopharmacol. 14:635-657 (1986).
13. M. Weiss, Commentary to van Rossum et al. [2].
14. M. Weiss, Residence time distributions in pharmacokinetics: behavioral and structural models, in Advanced Methods of Pharmacokinetics and Pharmacodynamics System Analysis (D'Argenio, Ed.), Plenum, New York, 1991, pp. 89-101.
15. D. O. Chanter, The determination of mean residence time using statistical moments: is it correct?, J. Pharmacokin. Biopharmacol. 13:93-100 (1985).
16. D. J. Cutler, Theory of the mean absorption time, and adjunct to conventional bioavailability studies, J. Pharm. Pharmacol. 30:476-478 (1978).
17. K. Yamaoka, T. Nakagawa, and T. Uno, Statistical moments in pharmacokinetics, J. Pharmacokin. Biopharmacol. 5:547-557 (1978).
18. W. R. Gillespie and P. Veng-Pedersen, The determination of mean residence time using statistical moments: it is correct, J. Pharmacokin. Biopharmacol. 13:549-554 (1985).
19. P. S. Collier, Mean residence time: some further considerations, Biopharmacol. Drug Disposition 10:443-451 (1989).
20. D. J. Cutler, A comment regarding mean residence times in non-linear systems, Biopharmacol. Drug Disposition 10:529-530 (1989).
21. N. A. Lassen and O. Henriksen, Tracer studies of peripheral circulations, in Tracer Kinetics and Physiological Modeling (R. M. Lambrecht and A. Rescigno, Eds.), Springer, Berlin, 1983, pp. 235-297.
22. W. Feller, An Introduction to Probability Theory and Its Applications, Vol. II, Wiley, New York, 1966.
23. J. Keilson, Markov Chain Models - Rarity and Exponentiality, Springer, New York, 1979.
24. M. Abramowitz and I. Stegun (Eds.), Handbook of Mathematical Functions. Dover, New York, 1965.
25. M. E. Wise, Interpreting both short and long term power laws in physiological clearance curves, Math. Biosci. 20:327-337 (1974).
26. M. E. Wise, Negative power functions of time in pharmacokinetics and their implications, J. Pharmacokin. Biopharmacol. 13:309-346 (1985).
27. G. T. Tucker, P. R. Jackson, G. C. A. Storey, and D. W. Holt, Amiodarone disposition: polyexponential, power and gamma functions, Eur. J. Clin. Pharmacol. 26:655-685 (1984).
28. M. E. Wise and G. J. J. M. Borsboom, Two exceptional sets of physiological clearance curves and their mathematical form: test cases?, Bull. Math. Biol. 51:579-596 (1989).
29. P. Hougaard, Survival models for heterogeneous populations derived from stable distributions, Biometrika 73:387-396 (1986).
30. O. O. Aalen, Modelling heterogeneity in survival analysis by the compound Poisson distribution, Ann. Appl. Probab. 2:951-972 (1992).
31. R. S. Chhikara and J. L. Folks, The Inverse Gaussian Distribution, Marcel Dekker, New York, 1989.
32. J. Keilson and H. F. Ross, Passage times distributions for Gaussian Markov (Ornstein-Uhlenbeck) statistical processes, Selected Tables Math. Stat. 3:233-327 (1975).
33. P. Lánský and C. E. Smith, The effect of a random initial value in neural first-passage-time models, Math. Biosci. 93:191-215 (1989).